🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/10/2009 | 45,67 | 46,03 | 44,99 | 45,00 | -1,60% | 2,28% | 683.900 |
| 15/10/2009 | 44,19 | 46,10 | 44,00 | 45,73 | +3,04% | 4,75% | 1.148.800 |
| 14/10/2009 | 44,61 | 44,68 | 43,91 | 44,38 | +0,07% | 1,73% | 940.700 |
| 13/10/2009 | 44,30 | 44,58 | 43,53 | 44,35 | +0,29% | 2,37% | 700.400 |
| 12/10/2009 | 44,21 | 44,71 | 43,85 | 44,22 | +0,84% | 1,95% | 590.600 |
| 09/10/2009 | 44,72 | 44,92 | 43,50 | 43,85 | -2,38% | 3,18% | 1.108.300 |
| 08/10/2009 | 46,32 | 46,99 | 44,74 | 44,92 | -2,20% | 4,86% | 792.900 |
| 07/10/2009 | 45,96 | 46,38 | 45,75 | 45,93 | -0,52% | 1,37% | 361.800 |
| 06/10/2009 | 45,67 | 46,93 | 44,59 | 46,17 | +1,85% | 5,12% | 1.124.600 |
| 05/10/2009 | 46,24 | 46,44 | 45,13 | 45,33 | -1,35% | 2,83% | 805.300 |
| 02/10/2009 | 47,69 | 48,29 | 45,79 | 45,95 | -4,13% | 5,24% | 704.000 |
| 01/10/2009 | 48,46 | 49,46 | 47,91 | 47,93 | -2,16% | 3,20% | 520.600 |
| 30/09/2009 | 49,01 | 49,72 | 48,26 | 48,99 | +0,51% | 2,98% | 675.400 |
| 29/09/2009 | 49,55 | 49,98 | 48,67 | 48,74 | -1,65% | 2,64% | 318.300 |
| 28/09/2009 | 48,91 | 49,91 | 48,91 | 49,56 | +1,29% | 2,04% | 326.100 |
| 25/09/2009 | 48,51 | 49,69 | 48,46 | 48,93 | +0,64% | 2,54% | 476.000 |
| 24/09/2009 | 47,77 | 48,64 | 47,62 | 48,62 | +1,82% | 2,14% | 437.400 |
| 23/09/2009 | 48,28 | 49,25 | 47,56 | 47,75 | -2,17% | 3,50% | 571.700 |
| 22/09/2009 | 49,52 | 49,92 | 48,53 | 48,81 | -1,54% | 2,81% | 834.600 |
| 21/09/2009 | 49,46 | 49,80 | 49,19 | 49,58 | +0,15% | 1,23% | 383.200 |
| 18/09/2009 | 50,11 | 50,45 | 49,49 | 49,50 | -1,18% | 1,92% | 690.400 |
| 17/09/2009 | 50,09 | 50,48 | 49,62 | 50,09 | -0,41% | 1,73% | 253.000 |
| 16/09/2009 | 50,06 | 50,46 | 49,48 | 50,30 | +0,41% | 1,96% | 358.600 |
| 15/09/2009 | 49,66 | 50,25 | 49,21 | 50,09 | +0,72% | 2,09% | 288.600 |
| 14/09/2009 | 49,69 | 49,83 | 49,46 | 49,73 | -0,04% | 0,73% | 374.400 |
| 11/09/2009 | 48,83 | 49,87 | 48,83 | 49,75 | +1,70% | 2,12% | 503.000 |
| 10/09/2009 | 48,63 | 49,43 | 48,56 | 48,92 | +0,87% | 1,79% | 450.800 |
| 09/09/2009 | 47,25 | 48,91 | 47,19 | 48,50 | +2,39% | 3,65% | 656.200 |
| 08/09/2009 | 46,75 | 47,79 | 46,16 | 47,37 | +1,63% | 3,48% | 571.800 |
| 04/09/2009 | 45,64 | 46,61 | 45,58 | 46,61 | +1,77% | 2,27% | 232.200 |